Epigenomics of Common Diseases 12-15 October 2012
Posted by Treasa Creavin, on 26 April 2012
Abstract deadline: 27 July 2012 | Registration deadline: 1 September 2012
Building on the success of last year’s event, ECD 2012 will bring together scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving field. This Wellcome Trust conference will discuss recent advances focusing on genome-wide approaches that are revolutionizing the field. Recent technological developments have made it possible to conduct epigenome-wide association studies (EWAS) to investigate the link between changes to the epigenome and the development of disease. Sessions will include: epigenomic studies across of a range of common diseases, including psychiatric and neurodevelopmental disorders and diseases of the immune system; model organisms and model systems; mathematical approaches to epigenomics; intergenerational and environmental effects; and translational epigenomics.
Abstract submission is strongly encouraged as a significant number of presentations will be selected from the abstracts.
Scientific organising committee:
Stephan Beck, University College London, UK
Susan Clark, The Garvan Institute of Medical Research, Australia
Andy Feinberg, Johns Hopkins University School of Medicine, USA
Anne Ferguson-Smith, University of Cambridge, UK
Venue:
Johns Hopkins University
Baltimore, MD, USA
Keynote Speakers:
Shelley Berger, University of Pennsylvania, USA
Bert Vogelstein, Johns Hopkins Kimmel Cancer Center, USA
Invited Speakers include:
Stephan Beck, University College London, UK
Jessica Connelly, University of Virginia, USA
Daniele Fallin, Johns Hopkins Bloomberg School of Public Health, USA
Andy Feinberg, Johns Hopkins University School of Medicine, USA
Doug Higgs, University of Oxford, UK
Tim Huang, University of Texas Health Science Center, USA
Barbara Knowles, ASTAR, Singapore
X. Shirley Liu, Dana-Farber/Harvard School of Public Health, USA
Shalini Oberdoerffer, National Cancer Institute, USA
Dirk Schübeler, Friedrich Miescher Institute for Biomedical Research, Switzerland
Amos Tanay, Weizmann Institute, Israel
Toshikazu Ushijima, National Cancer Center Research Institute, Japan
For more information: https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=298